Recent Updates
Recently added Catalysts
COLL

Collegium to Present at Upcoming Investor Conferences

Key Takeaway: STOUGHTON, Mass., April 01, 2019 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a specialty pharmaceutical company committed to being the leader in responsible pain management, today announced that management will present at the following investor conferences

Full Press Release Details

STOUGHTON, Mass., April 01, 2019 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a specialty pharmaceutical company committed to being the leader in responsible pain management, today announced that management will present at the following investor conferences in April:
The H.C. Wainwright Global Life Sciences Conference on Monday, April 8th at 11:10 a.m. GMT in London
The Needham Healthcare Conference on Wednesday, April 10th at 2:50 p.m. EDT in New York City
About Collegium Pharmaceutical, Inc.
Collegium is a specialty pharmaceutical company committed to being the leader in responsible pain management. Collegium’s headquarters are located in Stoughton, Massachusetts. For more information, please visit the company’s website at www.collegiumpharma.com.
Last updated: Apr 1, 2019